Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation - 18/04/17
, Heidi M. Connolly, MD, FACC a, Talha Niaz, MBBS b, Vidhushei Yogeswaran, BS c, Nathaniel W. Taggart, MD d, Muhammad Y. Qureshi, MBBS d, Joseph T. Poterucha, DO d, Arooj Razzaq Khan, MBBS a, David J. Driscoll, MD dBackground |
There are limited studies of thrombotic and embolic complications (TEC) in the adult Fontan population. The purpose of the study was to determine the prevalence, risk factors, and outcomes of TECs in this population.
Methods |
Retrospective review of adults with a previous Fontan operation, with follow-up at Mayo Clinic, 1994-2014. Systemic TEC was defined as intracardiac thrombus, ischemic stroke, or systemic arterial embolus. Nonsystemic TEC was defined as Fontan conduit/right atrial thrombus or pulmonary embolus.
Results |
We identified 387 patients with a mean (SD) age of 28 (7) years and a mean follow-up of 8 (2) years. An atriopulmonary connection (APC) was done for 286 patients (74%). Atrial arrhythmias were present in 278 (72%). There were 121 TECs (systemic n=36, nonsystemic n=85) in 98 patients (25%). Risk factors for systemic TEC were atrial arrhythmia (hazard ratio 2.28, P=.001) and APC (hazard ratio 1.98, P=.02); nonsystemic TEC also had similar risk factors. All 98 patients received warfarin. Warfarin was discontinued in 10 of 98 because of bleeding, and 8 of these 10 subsequently had a second TEC. Among the 82 patients who had follow-up imaging, 16 (20%) had resolution of thrombus. In total, 24 of 98 patients had a second TEC, most of whom had inadequate anticoagulation.
Conclusions |
Thrombotic and embolic complication was not uncommon; risk factors for TEC were APC and atrial arrhythmias. Most patients were treated successfully with warfarin alone. A second TEC occurred in most patients whose anticoagulation was discontinued because of bleeding events.
Le texte complet de cet article est disponible en PDF.Plan
| Funding source: None. |
|
| Conflict of interest: None. |
Vol 183
P. 10-17 - janvier 2017 Retour au numéro
Article précédent
- Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)
- Pavel Osmancik, Petr Tousek, Dalibor Herman, Petr Neuzil, Pavel Hala, Josef Stasek, Ludek Haman, Petr Kala, Martin Poloczek, Marian Branny, Jan Chovancik, Pavel Cervinka, Jiri Holy, Vlastimil Vancura, Richard Rokyta, Milos Taborsky, Tomas Kovarnik, David Zemanek, Petr Peichl, Sarka Haskova, Jiri Jarkovsky, Petr Widimsky, PRAGUE-17 Investigators
- Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish Men
- Daniel A. Steinhaus, Elizabeth Mostofsky, Emily B. Levitan, Kirsten S. Dorans, Niclas Håkansson, Alicja Wolk, Murray A. Mittleman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?